Jiangsu Hengrui | 600276

Stock Price
48.28
Daily Change
1.78 3.83%
Monthly
8.67%
Yearly
13.79%
Q1 Forecast
43.69



Peers Price Chg Day Year Date
Cspc Pharmaceutical 5.01 0.10 2.04% -21.35% Feb/21
Sino Biopharmaceutical 3.34 0.05 1.52% 5.36% Feb/21
Sh Fosun Pharma 25.63 0.05 0.20% 6.61% Feb/21
Zhangzhou Pientzehuang Pharmaceutical 204.59 0.80 0.39% -5.81% Feb/21
Kangmei Pharma 2.22 -0.02 -0.89% 18.09% Feb/21
Sh Pharmaceutical 19.66 -0.09 -0.46% 9.47% Feb/21
WuXi AppTec 68.41 4.05 6.29% 26.43% Feb/21

Indexes Price Day Year Date
SHANGHAI 3379 28.33 0.85% 13.08% Feb/21
SHANGHAI 50 2682 34.07 1.29% 10.24% Feb/21

Jiangsu Hengrui Me. traded at 48.28 this Friday February 21st, increasing 1.78 or 3.83 percent since the previous trading session. Looking back, over the last four weeks, Jiangsu Hengrui gained 8.67 percent. Over the last 12 months, its price rose by 13.79 percent. Looking ahead, we forecast Jiangsu Hengrui Me. to be priced at 43.69 by the end of this quarter and at 40.92 in one year, according to Trading Economics global macro models projections and analysts expectations.

Jiangsu Hengrui Pharmaceuticals Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical tablets, injections and raw materials. The Company's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty infusions and others. The Company distributes its products within domestic market and to overseas markets.